According to 10x Genomics 's latest financial reports the company's current EPS (TTM) is -$1.49. In 2022 the company made an earnings per share (EPS) of -$1.47 a decrease over its 2021 EPS that were of -$0.52.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.49 | 1.36% |
2022 | -$1.47 | 182.69% |
2021 | -$0.52 | -89.9% |
2020 | -$5.15 | 817.97% |
2019 | -$0.56 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | -$2.06 | 38.26% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | -$6.20 | 316.11% | ๐ฌ๐ง UK |
![]() Novavax NVAX | -$7.19 | 382.55% | ๐บ๐ธ USA |
![]() Novocure
NVCR | -$1.65 | 10.74% | Jersey |